Mari R. Candelore
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Pharmacological Effects and Assays, Adipose Tissue and Metabolism, Neuropeptides and Animal Physiology, Diabetes Treatment and Management
Most-Cited Works
- → Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.(1988)540 cited
- → Identification of Two Serine Residues Involved in Agonist Activation of the β-Adrenergic Receptor(1989)530 cited
- → Identification of residues required for ligand binding to the beta-adrenergic receptor.(1987)405 cited
- → Structural features required for ligand binding to the beta-adrenergic receptor.(1987)357 cited
- → Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core(1987)317 cited
- → Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression(1998)272 cited
- → Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity.(1987)262 cited
- → Allele-specific activation of genetically engineered receptors.(1991)233 cited
- → Mutational analysis of beta-adrenergic receptor glycosylation.(1990)216 cited
- → Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides(2000)199 cited